Oracle in talks to buy Cerner - WSJ
Reuters
Published Dec 16, 2021 07:54PM ET
(Reuters) - Enterprise software maker Oracle (NYSE:ORCL) is in talks to buy electronic medical records company Cerner (NASDAQ:CERN) in a deal that could be valued at $30 billion, the Wall Street Journal reported on Thursday, citing people familiar with the matter.
The transaction could bring Oracle a raft of health data to train and improve its artificial intelligence-based cloud services, boosting its presence in the healthcare sector.
If the deal materializes, it will be the biggest ever for Oracle, which has a market value of more than $280 billion, the WSJ report said, adding that the Oracle-Cerner deal could become one of the largest takeovers of 2021.
Cerner is the biggest seller of electronic health record software in the United States after Epic Systems Corp. In 2019, it had named Amazon (NASDAQ:AMZN) Web Services as its preferred cloud provider and said the two companies were collaborating on AI services for health companies.
Oracle and Cerner did not immediately respond to Reuters' request for comment.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.